U.S. Corlanor Promotional Audit Report 2017-2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 12, 2018--The “Corlanor 2017 U.S. Promotional Audit Report” report has been added to ResearchAndMarkets.com’s offering.
The 5 Key Questions Addressed by this Report:How many physicians were reached by Corlanor through reportable promotional activity in 2017 and how does this compare to its peer set in the Heart Failure market? What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity? How does Amgen’s depth of coverage vary within key specialties (e.g., Cardiology, Interventional Cardiology, Internal Medicine, Cardiac Electrophysiology, and Family Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians? How often are physicians receiving paid meals for Corlanor throughout the year (e.g., monthly, quarterly, annually)? Who were the most frequent meal recipients and top paid speakers for Corlanor in 2017? For more information about this report visit https://www.researchandmarkets.com/research/hrq77h/u_s_corlanor?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180912005961/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
KEYWORD: UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/12/2018 02:40 PM/DISC: 09/12/2018 02:40 PM